This announcement is a separate document:
天健会计师事务所（特殊普通合伙）关于浙江圣达生物药业股份有限公司向特定对象发行股票申请文件的审核问询函中有关财务事项的说明（修订稿）（2023年度财务数据更新版）
Instructions from Tianjian Certified Public Accountants (Special General Partnership) on financial matters in the review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets (revised draft) (2023 financial data update)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.